Invention Grant
- Patent Title: HLA-F-modified cells and methods
-
Application No.: US18166503Application Date: 2023-02-09
-
Publication No.: US12076346B2Publication Date: 2024-09-03
- Inventor: Ruby Yanru Tsai , Alfonso Farruggio , Xiuling Chi , Kai Wang
- Applicant: APPLIED STEMCELL, INC.
- Applicant Address: US CA Milpitas
- Assignee: APPLIED STEMCELL, INC.
- Current Assignee: APPLIED STEMCELL, INC.
- Current Assignee Address: US CA Milpitas
- Agency: Jun He Law Offices P.C
- Agent James J. Zhu
- Main IPC: A61K35/17
- IPC: A61K35/17 ; C07K14/705 ; C07K14/74 ; C07K16/28 ; C12N5/0735 ; G01N33/50

Abstract:
The present disclosure provides compositions and methods for cell transplantation therapy based on forced expression of an exogenous HLA-F protein in donor cells to be transplanted into a subject. In some embodiments, the donor cells express an exogenous chimeric HLA-F protein comprising an extracellular region comprising an HLA-F alpha 1 domain, an HLA alpha 2 domain, an HLA-F alpha 3 domain, a linker and a β2m protein.
Public/Granted literature
- US20230233610A1 HLA-F-MODIFIED CELLS AND METHODS Public/Granted day:2023-07-27
Information query
IPC分类: